Segmentation, Major Trends, and Competitive Overview of the Metabolomics Market

The metabolomics market is on track for impressive expansion as scientific advancements and healthcare innovations continue to gain momentum. With growing interest in personalized medicine and cutting-edge analytical technologies, this sector is set to experience rapid development over the coming years. Here is a detailed overview of the market outlook, key players, emerging trends, and segmentation within the metabolomics industry.

Projected Market Growth and Size of the Metabolomics Market by 2030
The global metabolomics market is anticipated to grow significantly, reaching a valuation of $9.29 billion by 2030. This marks a strong compound annual growth rate (CAGR) of 17.3%. The factors driving this growth include progress in bioinformatics tools, a heightened emphasis on personalized medicine, increasing applications in nutrigenomics, expanding research into metabolic pathways, and greater integration of metabolomics in clinical diagnostics. Key trends forecasted to shape the market include the fusion of precision medicine with metabolomic profiling, broader adoption of cloud-based data platforms for metabolomics, AI-powered recognition of metabolite patterns, automation in high-throughput metabolomics workflows, and the use of IoT devices for real-time metabolic monitoring.

Download a free report of the metabolomics market report:
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Companies That Influence the Metabolomics Industry
Several prominent corporations play a significant role in the metabolomics market, including Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, PerkinElmer Inc., LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Charles River Laboratories International Inc., Metabowerke GmbH, Metabolomic Diagnostics, and Phenomenex Inc.

Significant Acquisition to Strengthen Market Position
In June 2025, Bruker Corporation, a US-based leader in scientific instruments and life-science technology, acquired Biocrates Life Sciences AG for an undisclosed amount. This strategic move aims to enhance Bruker's multiomics capabilities by incorporating metabolomics into its product range. This acquisition expands Bruker's offerings from instruments alone to include standardized metabolite-analysis kits, assays, software, and services. Biocrates, headquartered in Austria, specializes in mass spectrometry-based quantitative analysis of metabolites and lipids, providing standardized kits, software, and contract research services that enable laboratories to measure hundreds to thousands of metabolites from very small biological samples.

View the full metabolomics market report:
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Developments in Metabolomics Market Trends
Companies in the sensory analysis devices sector are investing in advanced technologies like electronic tongue systems to improve taste evaluation accuracy and consistency, which is crucial for quality control and product development. The electronic tongue employs sensor arrays combined with sophisticated algorithms to mimic the human tongue's ability to detect and differentiate tastes, offering objective and rapid flavor analysis.

A notable example of innovation occurred in December 2023 when the Daegu Gyeongbuk Institute of Science & Technology in South Korea partnered with the Korea Advanced Institute of Science & Technology to develop a sophisticated electronic tongue. This device replicates the human gustatory system by integrating multiple taste sensors with deep learning algorithms, enabling precise and objective quantification of tastes such as saltiness, sourness, bitterness, and sweetness.

Detailed Segmentation of the Metabolomics Market
The report segments the metabolomics market into distinct categories for clarity:

1) By Product and Service:
- Metabolomics Instruments
- Metabolomics Bioinformatics Tools and Services

2) By Indication:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Other Indications

3) By Application:
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Personalized Medicine
- Other Applications

Further Breakdown of Market Subsegments
Within metabolomics instruments, the market includes chromatography instruments such as gas chromatography and liquid chromatography, mass spectrometry instruments like LC-MS and GC-MS, and nuclear magnetic resonance (NMR) instruments. For bioinformatics tools and services, subcategories cover software applications for data analysis, statistical modeling, metabolomic databases, consulting services for data interpretation and analytical support, as well as training and support services.

This comprehensive segmentation highlights the diverse and specialized nature of the metabolomics market, reflecting its critical role in advancing biomedical research and personalized healthcare.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.